References
- 1. Bazin APE. Leçon Theorique et Cliniquas sur les Syphilides Rediquées par le Fournier. Paris: Adrian Delahayer; 1859.
- 2. Neisser A. Malignant syphilis. Br J Dermatol. 1897;9:11-26.
- 3. Haslund A. Syphilis maligna. Arch Dermatol Syph. 1897;38(1):345-92.10.1007/BF01997847
- 4. Shulkin D, Tripoli L, Abell E. Lues maligna in a patient with human immunodeficiency virus infection. Am J Med. 1988;85(3):425-7.10.1016/0002-9343(88)90600-6
- 5. Mohan GC, Ali RA, Isache CL, Sharma RK, Prniciaro C. Malignant syphilis: ostacerous, ulceronecrotic lesions in a patient with human immunodeficiency virus. Dermatol Online J 2017 Jan 15; 23 (1)10.5070/D3231033673
- 6. Tucker JD, Shah S, Jarell AD, Tsai KY, Zembowicz A, Kroshinsky D. Lues maligna in early HIV infection case report and review of the literature. Sex Transm Dis. 2009;36(8):512-4.10.1097/OLQ.0b013e3181a2a946
- 7. Savage EJ, Hughes G, Ison C, Lowndes CM; European Surveillance of Sexually Transmitted Infections network. Syphilis and gonorrhoea in men who have sex with men: a European overview. Euro Surveill. 2009;14(47):pii: 19417.10.2807/ese.14.47.19417-en
- 8. Bjekić M, Šipetić S. An outbreak of early syphilis in patients registered at City Institute for Skin and Venereal Diseases in Belgrade from 2010 to 2012: a case series of 86 patients. Serbian Journal of Dermatology and Venereology. 2013;5(2):65-71.10.2478/sjdv-2013-0006
- 9. Institute of Public Health of Serbia “Dr Milan Jovanovic Batut”. Center for Disease Control and Prevention. Report of infectious diseases in the Republic of Serbia in 2016. Belgrade: Institute of Public Health of Serbia “Dr Milan Jovanovic Batut”; 2017. p. 62-73.
- 10. Bjekić M, Šipetić-Grujičić S, Begović-Vuksanović B, Rafailović N, Vlajinac H. Syphilis resurgence in Belgrade, Serbia in the new millennium - an outbreak in 2014. Cent Eur J Public Health. 2017;25(4):277-81.10.21101/cejph.a4525
- 11. Patton ME, Su JR, Nelson R, Weinstock H; Centers for Disease Control and Prevention (CDC). Primary and secondary syphilis - United States, 2005-2013. MMWR Morb Mortal Wkly Rep. 2014;63(18):402-6.
- 12. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis. 2004;4(7):456-66.10.1016/S1473-3099(04)01061-8
- 13. Baughn RE, Musher DM. Secondary syphilitic lesions. Clin Microbiol Rev. 2005;18(1):205-16.10.1128/CMR.18.1.205-216.200554417415653827
- 14. Bjekić M. Secondary syphilis in patients treated at the City Institute for Skin and Venereal Diseases in Belgrade from 2010 to 2014. Serbian Journal of Dermatology and Venereology. 2015;7(2):53-60.10.1515/sjdv-2015-0005
- 15. Fisher DA, Chang LW, Tuffanelli DL. Lues maligna: presentation of a case and a review of the literature. Arch Dermatol. 1969;99(1):70-3.10.1001/archderm.1969.01610190076014
- 16. Balagula Y, Mattei PL, Wisco OJ, Erdag G, Chien AL. The great imitator revisited: the spectrum of atypical cutaneous manifestations of secondary syphilis. Int J Dermatol. 2014;53(12):1434-41.10.1111/ijd.1251825312512
- 17. Yang CJ, Lee NY, Lin YH, Lee HC, Ko WC, Liao CH, et al. Jarisch-Herxheimer reaction after penicillin therapy among patients with syphilis in the era of the HIV infection epidemic: incidence and risk factors. Clin Infect Dis. 2010;51(8):976-9.10.1086/65641920825309
- 18. Belum GR, Belum VR, Chaitanya Arudra SK, Reddy BS. The Jarisch-Herxheimer reaction: revisited. Travel Med Infect Dis. 2013;11(4):231-7.10.1016/j.tmaid.2013.04.00123632012
- 19. Lejman K, Starzycki Z. Syphilis maligna praecox. A case report. Br J Vener Dis. 1972;48(3):194-9.
- 20. Bayramgürler D, Bilen N, Yildiz K, Sikar A, Yavuz M. Lues maligna in a chronic alcoholic patient. J Dermatol. 2005;32(3):217-9.10.1111/j.1346-8138.2005.tb00749.x15863871
- 21. Hofmann UB, Hund M, Bröcker EB, Hamm H. “Lues maligna” in a female patient with diabetes. J Dtsch Dermatol Ges. 2005;3(10):780-2.10.1111/j.1610-0387.2005.05734.x16194156
- 22. Schöfer H, Imhof M, Thoma-Graber E, Brockmeyer NH, Hartmann M, Gerken G, et al. Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med. 1996;72(3):176-81.